EP1317270 - EXEMESTANE FOR THE TREATMENT OF OESTROGEN-DEPENDENT CANCERS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 23.07.2010 Database last updated on 12.11.2024 | Most recent event Tooltip | 23.07.2010 | Application deemed to be withdrawn | published on 25.08.2010 [2010/34] | Applicant(s) | For all designated states Pfizer Italia S.r.l. Strada Statale 156 Km. 50 04010 Latina / IT | For all designated states Pharmacia & Upjohn Company LLC 7000 Portage Road Kalamazoo, MI 49001 / US | [2007/04] |
Former [2006/31] | For all designated states Pfizer Italia S.r.l. Strada Statale 156 Km. 50 04010 Latina / IT | ||
For all designated states Pharmacia & Upjohn Company LLC 301 Henrietta Street Kalamazoo, MI 49001 / US | |||
Former [2005/22] | For all designated states Pharmacia Italia S.p.A. Via Robert Koch 1.2 20152 Milano / IT | ||
For all designated states Pharmacia & Upjohn Company LLC 301 Henrietta Street Kalamazoo, MI 49001 / US | |||
Former [2003/24] | For all designated states Pharmacia Italia S.p.A. Via Robert Koch 1.2 20152 Milano / IT | ||
For all designated states Pharmacia & Upjohn Company 301 Henrietta Street Kalamazoo, MI 49007 / US | Inventor(s) | 01 /
DI SALLE, Enrico Viale Andrea Doria, 5 I-20124 Milano / IT | 02 /
PISCITELLI, Gabriella Via Piacenza, 13 I-20135 Milano / IT | 03 /
MASSIMINI, Giorgio Via Padre Carlo Vigevano, 26 I-20081 Abbiategrasso / IT | 04 /
PURANDARE, Dinesh 6 Macintosh Road Branchburg, NJ 08876 / US | 05 /
MARTINI, Alessandro Via Desiderio da Settignano, 14 I-20149 Milano / IT | 06 /
MUGGETTI, Lorena Via Trento, 38 I-20036 Meda / IT | [2003/24] | Representative(s) | Modiano, Micaela Nadia, et al Modiano Josif Pisanty & Staub Ltd Thierschstrasse 11 80538 München / DE | [N/P] |
Former [2009/36] | Modiano, Micaela Nadia, et al Modiano Josif Pisanty & Staub Ltd Thierschstrasse 11 80538 München / DE | ||
Former [2004/35] | Modiano, Micaela Nadia, et al Modiano, Josif, Pisanty & Staub, Baaderstrasse 3 80469 München / DE | ||
Former [2003/24] | Longoni, Alessandra Pharmacia Italia S.p.A., Patent Department, Viale Pasteur 10 20014 Nerviano (MI) / IT | Application number, filing date | 01969689.7 | 31.08.2001 | [2003/24] | WO2001EP10172 | Priority number, date | US20000658052 | 08.09.2000 Original published format: US 658052 | [2003/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO0220020 | Date: | 14.03.2002 | Language: | EN | [2002/11] | Type: | A1 Application with search report | No.: | EP1317270 | Date: | 11.06.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.03.2002 takes the place of the publication of the European patent application. | [2003/24] | Search report(s) | International search report - published on: | EP | 14.03.2002 | Classification | IPC: | A61K31/5685, A61P35/00 | [2003/24] | CPC: |
A61K45/06 (EP,US);
A61K31/5685 (EP,KR,US);
A61P35/00 (EP);
A61P43/00 (EP);
A61P5/32 (EP)
| C-Set: |
A61K31/5685, A61K2300/00 (EP,US)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/24] | Extension states | AL | 07.04.2003 | LT | 07.04.2003 | LV | 07.04.2003 | MK | 07.04.2003 | RO | 07.04.2003 | SI | 07.04.2003 | Title | German: | EXEMESTAN ZUR BEHANDLUNG VON AUF ÖSTROGEN ABHÄNGIGEN KREBS | [2003/24] | English: | EXEMESTANE FOR THE TREATMENT OF OESTROGEN-DEPENDENT CANCERS | [2003/24] | French: | UTILISATION D'EXEMESTANE COMME AGENT DE CHIMIO-PREVENTION | [2003/24] | Entry into regional phase | 07.04.2003 | National basic fee paid | 07.04.2003 | Designation fee(s) paid | 07.04.2003 | Examination fee paid | Examination procedure | 22.03.2002 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 07.04.2003 | Examination requested [2003/24] | 22.05.2003 | Amendment by applicant (claims and/or description) | 07.10.2005 | Despatch of a communication from the examining division (Time limit: M06) | 01.08.2006 | Reply to a communication from the examining division | 02.07.2007 | Despatch of a communication from the examining division (Time limit: M06) | 20.03.2008 | Reply to a communication from the examining division | 02.03.2010 | Application deemed to be withdrawn, date of legal effect [2010/34] | 08.04.2010 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2010/34] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 20.03.2008 | Request for further processing filed | 20.03.2008 | Full payment received (date of receipt of payment) Request granted | 08.04.2008 | Decision despatched | 25.07.2006 | Request for further processing filed | 25.07.2006 | Full payment received (date of receipt of payment) Request granted | 08.08.2006 | Decision despatched | Fees paid | Renewal fee | 06.08.2003 | Renewal fee patent year 03 | 06.08.2004 | Renewal fee patent year 04 | 08.08.2005 | Renewal fee patent year 05 | 07.08.2006 | Renewal fee patent year 06 | 03.08.2007 | Renewal fee patent year 07 | 08.08.2008 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 31.08.2009 | 09   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [DX]US4808616 (BUZZETTI FRANCO [IT], et al) [DX] 4,5 * abstract * * column 1, line 5 - line 16 * * examples 8,9 * * claims 1-7 *; | [X]WO0037107 (SEARLE & CO [US], et al) [X] 4,5 * abstract * * page 141, line 22 * * claims 1,58,115,142,145 *; | [X]WO9729735 (UNIV MONASH [AU], et al) [X] 4,5 * abstract * * page 26, line 5 * * claims 23,30 *; | [EL]WO0164193 (PHARMACIA & UPJOHN SPA [IT], et al) [EL] 4,5 * abstract * * page 1, line 5 - page 2, line 24 * * page 4, line 9 - line 17 * * page 5, line 3 - line 13 * * claims 1-17 * * L: Priority *; | [PXL]WO0069467 (PHARMACIA & UPJOHN SPA [IT], et al) [PXL] 4,5 * abstract * * page 1, line 5 - line 9 * * page 4, line 22 - page 7, line 13 * * L: Priority * | [X] - LONNING, P.E. ET AL., "Activity of exemestane in metastatic breast cancer after failure of non-steroidal aromatase inhibitors: a phase II trial", JOURNAL OF CLINICAL ONCOLOGY, (200006), vol. 18, no. 11, pages 2234 - 2244, XP001034132 [X] 4,5 * abstract * | [X] - BUZZETTI, F; DI SALLE, E; LONGO, A; BRIATICO, G, ""Synthesis and aromatase inhibition by potential metabolites of exemestane (6-methylenandrosta-1,4-diene-3,17-dione", STEROIDS, (1993), vol. 58, no. 11, pages 527 - 532, XP001037784 [X] 4,5 * abstract * * introduction * DOI: http://dx.doi.org/10.1016/0039-128X(93)90029-M |